Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARC101 |
Trade Name | |
Synonyms | ARC 101|ARC-101 |
Drug Descriptions |
Limited information is currently available on ARC101, a putative bispecific T-cell engager targeting CLDN6 and CD3 (Mar 2025). |
DrugClasses | CD3 Antibody 107 CLDN6 Antibody 10 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARC101 | ARC101 | 0 | 1 |